← Back to catalogue

Atellica IM CA 19-9

FDA UDI

Class II (US FDA UDI)

by Siemens Healthcare Diagnostics

Identity

Trade Name
Atellica IM CA 19-9 FDA UDI
Generic Name
Cancer antigen 19-9 (CA19-9) IVD, kit, chemiluminescent immunoassay FDA UDI
Device Name
CA 19-9 Atellica IM - RGT 250T FDA UDI
Model / Reference
10995489 FDA UDI
Description
CA 19-9 Atellica IM - RGT 250T FDA UDI

Identifiers

Catalog Number
10995489 FDA UDI
Primary DI / UDI-DI
00630414598161 FDA UDI
510(k) Number
K031393 FDA UDI
FDA Product Code
NIG FDA UDI
GMDN Term
Cancer antigen 19-9 (CA19-9) IVD, kit, chemiluminescent immunoassay FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.6010 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cancer antigen 19-9 (CA19-9) IVD, kit, chemiluminescent immunoassay

Atellica IM CA 19-9 by Siemens Healthcare Diagnostics — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cancer antigen 19-9 (CA19-9) IVD, kit, chemiluminescent immunoassay.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI f900e35d-a993-4ae0-9002-715e9a9c0e41 37 fields · synced May 30, 2026